|
* Cuthbertson FM, Davies M, McKibbin M.. Is screening for interferon retinopathy in hepatitis C justified? Br J Ophthalmol. 2004;88(12):1518-20
* Foroozan R. Unilateral pallid optic disc swelling and anemia associated with interferon alpha treatment. J Neuroophthalmol. 2004 Mar;(2):98-9.
* Sandner D, Pillunat LE. Reversible Perimacular Retinopathy by Long-Time Interferon alpha Therapy. Klin Monatsbl Augenheilkd. 2004 Jan;221(1):63-6.
* Vardizer Y, Linhart Y, Loewenstein A, Garzozi H, Mazawi N, Kesler A.Interferon-alpha-associated bilateral simultaneous ischemic optic neuropathy.J Neuroophthalmol. 2004 Mar;24(1):98-9.
* Awasthi N, Wagner BJ. Interferon-gamma induces apoptosis of lens alphaTN4-1 cells and proteasome inhibition has an antiapoptotic effect.Invest Ophthalmol Vis Sci. 2004 Jan;45(1):222-9.
* Tsolakos A, Zalatimo N. Hepatitis C: a review of diagnosis, management, and ocular complications from treatment. Optometry. 2003 Aug;74(8):517-23.
* Matsuo T, Takabatake R.. Multiple sclerosis-like disease secondary to alpha interferon. Ocul Immunol Inflamm. 2002 Dec;10(4):299-304.
* Schulman JA, Liang C, Kooragayala LM, King Posterior segment complications in patients with hepatitis C treated with interferon and ribavirin.J. Ophthalmology. 2003 Feb;110(2):437-42.
* Jung L.S., Ciola F.B., Conceição R.D.O, SilvaA.E.B, Moraes N.S.B, Ocular changes due to systemic alpha-interferon therapy for hepatitis C. Alterações oculares por uso sistêmico de alfa-interferon em pacientes com hepatite C. Arq Bras Oft. 2004;67(6):917-20.
|
